Navigation Links
Gladstone and Lundbeck collaborate to study neurovascular disease

The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD, and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging at the Gladstone Institute of Neurological Disease.

Dr. Akassoglou's pioneering research on blood proteins identified novel targets for therapeutic intervention in neurological diseases. Dr. Akassoglou has also developed imaging techniques to study neurovascular diseases in vivo, which will enable a better understanding of the origins and progress of these diseases, and thus find more practical strategies for disease detection and treatment.

"Our research on the role of blood proteins in brain functions has identified new targets for therapeutic intervention in multiple sclerosis and other neurological diseases," said Dr. Akassoglou. "Collaborating with the outstanding scientists at Lundbeck, offers great hope for discovering what triggers these diseases and developing novel therapeutic agents."

"Through its basic research into the origins of neurological disease, Gladstone has built an impressive knowledge into potential strategies and targets for treating devastating neurological diseases, such as multiple sclerosis and Alzheimer's disease," said Peter Hngaard Andersen, Executive Vice President of Research, H. Lundbeck A/S. "We are looking forward to applying new imaging technologies to help evaluate and translate these discoveries into patient benefits."

"Lundbeck is a truly visionary company with a well-focused strategy for building a pipeline to treat neurological disease," said Gladstone president R. Sanders Williams, MD. "We are enthusiastic about the potential of this important collaboration."

While the Gladstone Institutes was established in 1979 as an independent, non-profit biomedical research institute, the Gladstone Center for Translational Research was established in 2006 to move its most advanced discoveries into preclinical development with biotechnology and pharmaceutical industry partners. Examples of such collaborations include a research program with Merck on Alzheimer's disease and projects with Gilead and JT Pharma on HIV. The Taube-Koret Center for Huntington's Disease Research is another component that focuses on developing disease models and drug targets for Huntington's and related neurodegenerative disease.


Contact: Valerie Tucker
Gladstone Institutes

Related medicine news :

1. Gladstones Robert Mahley to receive Research!America advocacy award
2. Gladstones Deepak Srivastava elected to the American Academy of Arts and Sciences
3. Hope Phones, IntraHealth and FrontlineSMS:Medic Collaborate on Phone Donation Campaign to Support Health Workers in Africa
4. The Advisory Board Company and HIMSS Analytics to Collaborate to Solve Health Care IT Challenges
5. Philips Collaborates with Microsoft to Enhance Healthcare Efficiencies and Productivity
6. FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs
7. Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants
8. Doctors must collaborate so that patients get full benefit of tamoxifen treatment
9. PeopleStreme Collaborates with SkillSoft for Learning Management Content
10. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
11. Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend
Post Your Comments:
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: